Copyright
©The Author(s) 2023.
World J Clin Cases. Jan 26, 2023; 11(3): 610-620
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.610
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.610
Groups | T0 | T1 | T2 | T3 | |
MAP (mmHg) | Group C | 90.4 ± 6.1 | 73.4 ± 6.11 | 77.0 ± 5.81 | 88.6 ± 5.4 |
Group B1 | 89.4 ± 5.4 | 81.7 ± 4.1 | 85.3 ± 4.0 | 88.3 ± 3.8 | |
Group B2 | 89.5 ± 5.1 | 78.3 ± 5.02 | 82.4 ± 4.22 | 88.5 ± 4.1 | |
HR (bpm) | Group C | 81.8 ± 8.8 | 68.8 ± 7.21 | 72.1 ± 6.9 | 79.9 ± 6.0 |
Group B1 | 80.3 ± 9.0 | 73.2 ± 8.5 | 74.9 ± 8.0 | 78.3 ± 6.2 | |
Group B2 | 81.9 ± 9.3 | 74.7 ± 9.8 | 76.2 ± 8.2 | 80.1 ± 6.1 |
- Citation: Guo F, Sun DF, Feng Y, Yang L, Li JL, Sun ZL. Efficacy and safety of propofol target-controlled infusion combined with butorphanol for sedated colonoscopy. World J Clin Cases 2023; 11(3): 610-620
- URL: https://www.wjgnet.com/2307-8960/full/v11/i3/610.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i3.610